GL1X · GenesisL1 explorer

MolNFT v1 · #142929 · protein

Crystal structure of human fto in complex with small-molecule inhibitors

6AK4: “Crystal structure of human fto in complex with small-molecule inhibitors”. X-ray diffraction, 2 ligands (PD9, ZN). MolNFT v1 #142929 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
6AK4
Type
protein
Length
425 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
UniProt
Q9C0B1
Ligands
PD9, ZN

Structure

x-ray diffraction · 1 distinct chain.

ChainMoleculeTypeResiduesSecondary structureUniProt
A—protein425—Q9C0B1

Ligands and binding sites

  • PD9 · (~{E})-2-cyano-~{N},~{N}-diethyl-3-[3-nitro-4,5-bis(oxidanyl)phenyl]prop-2-enamide · ligand · chains A
  • ZN · Zinc ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Compared structures

  • 6AK4 · Crystal structure of human FTO in complex with small-molecule inhibitors · the same entry in another collection · chain A against A, TM-score 1.00
  • Q9C0B1 · AlphaFold monomer V2.0 prediction for alpha-ketoglutarate-dependent dioxygenase fto… · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.